CD8A and neoplasm: Also, CD8+ T cells have been shown to be a potent mediator of anti-tumor immunity, and tumor-directed immune-based therapies have focused on eliciting a cytotoxic T cell (CTL) response, primarily because CTLs can directly kill tumors and target cells [17–22].